Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Clinical Diabetes

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1610884

This article is part of the Research TopicInnovative Therapeutic Strategies for Managing Diabetic Foot Ulcers and Mitigating Associated ComplicationsView all 6 articles

Development of an XGBoost-based prediction model for wound recurrence risk in diabetic foot ulcer patients treated with antibiotic-loaded bone cement

Provisionally accepted
Yi  ZhangYi Zhang1,2Xingyu  SunXingyu Sun3*Cheng  ChengCheng Cheng2Nianzong  HouNianzong Hou4Shiliang  HanShiliang Han2Xin  TangXin Tang1*
  • 1First Affiliated Hospital of Dalian Medical University, Dalian, China
  • 2Zibo Central Hospital, Shandong, China
  • 3Jining University, Jining, China
  • 4Tongji University, Shanghai, Shanghai Municipality, China

The final, formatted version of the article will be published soon.

This study aims to improve the surgical cure rate, develop interventions to reduce the incidence of postoperative nonunion or recurrence of diabetic foot wounds, and formulate an optimal prediction model to quantify the predictive risk value of antibiotic bone-cement failure in the treatment of diabetic foot.The training and test sets were created once the cases were collected. Based on feature correlation, feature importance, and feature weight, LASSO analysis, random forest, and the Pearson correlation coefficient approach were used to identify the features. Artificial neural network, support vector machine, and XGBoost prediction models were built according to the selected optimal features. The receiver operating characteristic curve, precision-recall (PR) curve, and decision curve analysis were utilized to validate the performance of the models and select the optimal prediction model. Lastly, an independent test set was created to assess and determine the best model's capacity for generalization.A comparative analysis revealed that the area under the curve (AUC) for the training set of the PRL-XGBoost prediction model was 0.85 and that for the test set was 0.71. This finding suggests that the model exhibits good predictive ability. Moreover, the PR-AUC value of the prediction model was 0.97, indicating that it demonstrates good resistance to overfitting. Additionally, the DCA curve showed that the PRL-XGBoost prediction model has significant application value and practicality. Therefore, PRL-XGBoost was found to be the most effective prediction model.The findings from this study prove that γ -glutamyl transpeptidase, lipoprotein A, peripheral vascular disease, peripheral neuropathy, and white blood cells are the key indices that affect the surgical outcome. These parameters determine the nutritional and immune status of the lower limb endings, leading to ulceration, infection, and nonunion of the diabetic foot. Hence, the PRL-XGBoost prediction model can be applied for the preoperative evaluation and screening of patients with diabetic foot treated with antibiotic bone cement, resulting in favorable clinical outcomes.

Keywords: XGBoost, Decision curve analysis, Feature Selection, diabetic foot ulceration; antibiotic bone cement, Diabetic Foot, Diabetes Mellitus

Received: 21 Apr 2025; Accepted: 07 Jul 2025.

Copyright: © 2025 Zhang, Sun, Cheng, Hou, Han and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xingyu Sun, Jining University, Jining, China
Xin Tang, First Affiliated Hospital of Dalian Medical University, Dalian, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.